“initial-public-offering” Archives

in
Entry Author Date Location
On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO 07/06/20 San Francisco
Report: IPO Activity Picking Back Up Following Quiet, Volatile Q3 09/25/19 San Diego
Cloudflare’s $525M IPO Emboldens Already-Confident Internet Booster 09/13/19 San Francisco
After Drought, Digital Health’s Summer of IPOs Brings Validation 08/14/19 National
VMWare Plans to Acquire Bitfusion for Application-Enhancing Software 07/18/19 Texas
IPO Scorecard: CrowdStrike Gains 70 Percent on First Trading Day 06/12/19 San Francisco
Inhibrx, Fresh Off $40M Funding to Advance Cancer Drugs, Eyes IPO 06/03/19 San Diego
CrowdStrike IPO: Cybersecurity Firms Defend Themselves, and You 05/29/19 San Francisco
Endpoint Security Company CrowdStrike Files Publicly for IPO 05/14/19 San Francisco
Uber Completes $8.1B Public Market Debut in Spite of Tumultuous Past 05/09/19 San Francisco
Peloton Therapeutics Plans IPO for Kidney Cancer Drug Clinical Trials 04/29/19 Texas
San Antonio Wound-Care Company Eyes (Another) Initial Public Offering 04/18/19 Texas
Plant-Breeding Biotech Cibus Delays IPO, Citing Market Conditions 02/14/19 San Diego
Gossamer Bio Adds $276M in Second Biotech “Unicorn” IPO of 2019 02/07/19 San Diego
Dell Sets Return to Public Market With Shareholder OK of VMware Deal 12/11/18 Texas
Post-IPO Chat With CEO of Anaplan as Its Trading Price Surge Holds 10/17/18 San Francisco
Anaplan Ups Estimate For Its IPO Haul; Allogene IPO Raises $288M 10/10/18 San Francisco
Eventbrite Targets $200M IPO as Tech, Biotech Markets Remain Hot 08/23/18 San Francisco
San Antonio’s Earth Class Mail Buys Digital Receipt Maker Shoeboxed 08/22/18 Texas
You’ve Got Mail: Earth Class Mail Revamps After New Execs Take Over 08/09/18 Texas
Elanco’s IPO Would Free Eli Lilly to Focus on Pharmaceuticals 08/03/18 Indiana
DocuSign Agrees to Acquire Chicago Software Maker SpringCM for $220M 07/31/18 San Francisco
Former Zulily Employees Announce Digital Ad Platform New Engen 07/26/18 Seattle
Hype―and Skepticism―Remains for Dell’s Return to the Public Market 07/10/18 Texas
Neon Therapeutics, Translate Bio Join the Ranks of IPO Hopefuls 06/04/18 Boston
Aravive Seeks Nasdaq Perch Via Reverse Merger With Biotech Versartis 06/04/18 Texas
Bio Roundup: Moderna’s Billions, Cytokine Bets, Shire Acquired & More 05/11/18 National
Evelo IPO Raises $85M for Microbiome Drugs in Inflammation, Cancer 05/09/18 Boston
Pivotal Notches $555M IPO to Boost Enterprise Software in the Cloud 04/20/18 San Francisco
Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More 04/20/18 National
Page 1 of 5 next page »